Ceylon Cinnamon and Blood Sugar: What the Evidence Shows

Ceylon cinnamon and blood sugar management is a topic of growing interest, particularly among people looking for complementary approaches alongside conventional diabetes care. Ceylon cinnamon (Cinnamomum verum), often called 'true cinnamon', differs from the more common Cassia variety in both composition and safety profile. Laboratory studies suggest certain compounds in cinnamon may influence insulin sensitivity and slow glucose absorption, but clinical evidence in humans remains limited and inconsistent. This article examines what the current research shows, how Ceylon cinnamon compares to UK clinical guidelines, and what to consider before taking it alongside prescribed diabetes medication.

Can Ceylon cinnamon really help lower blood sugar levels?

Ceylon cinnamon may modestly influence blood sugar through cinnamaldehyde and polyphenols, but evidence from human trials is weak and it should not replace evidence-based diabetes treatment.

Ceylon cinnamon may have a modest effect on blood sugar levels in some people, but the evidence is not strong enough to recommend it as a treatment for diabetes or prediabetes. Ceylon cinnamon (Cinnamomum verum), sometimes called 'true cinnamon', is distinct from the more widely available Cassia cinnamon (Cinnamomum cassia). Ceylon cinnamon contains lower levels of coumarin, a compound associated with liver toxicity at high doses, though the exact coumarin content can vary between products and batches.^[2][3] When buying a supplement, check the label confirms the species as Cinnamomum verum rather than Cinnamomum cassia.

The proposed mechanism centres on compounds within cinnamon, particularly cinnamaldehyde and certain polyphenols, which laboratory and animal studies suggest may improve insulin sensitivity by influencing insulin receptor signalling and slowing gastric emptying.^[1][6] Slowing the rate at which food leaves the stomach can reduce the speed at which glucose enters the bloodstream after a meal, potentially blunting post-meal blood sugar spikes.

These mechanisms have been demonstrated primarily in cell and animal studies. Translating these findings to meaningful clinical benefit in humans is far less straightforward, and the effect sizes observed in human trials have generally been small. Culinary amounts of cinnamon are unlikely to achieve the doses studied in trials and should not be regarded as a substitute for evidence-based diabetes care. Ceylon cinnamon should therefore be regarded as a complementary area of interest rather than an evidence-based intervention for blood sugar management.

People who are pregnant, breastfeeding, or giving supplements to children, and those with pre-existing liver disease, should avoid high-dose cinnamon supplements and seek advice from a GP or pharmacist before use.

What does the current evidence say about cinnamon and diabetes?

Current evidence is mixed and inconclusive; systematic reviews highlight poor study quality, and most trials used Cassia rather than Ceylon cinnamon, limiting firm conclusions.

The current clinical evidence on cinnamon and blood sugar control is mixed and inconclusive, with no robust consensus supporting its routine use in people with type 2 diabetes or prediabetes. Several small randomised controlled trials have reported modest reductions in fasting blood glucose and, in some cases, HbA1c (a measure of average blood sugar over approximately three months) in people taking cinnamon supplements compared with placebo.^[9][10] However, systematic reviews and meta-analyses have consistently highlighted the poor quality of the underlying studies, including small sample sizes, short durations, variable doses, and the use of different cinnamon species.

Published systematic reviews and meta-analyses, including analyses drawing on randomised controlled trial data, have found that while some trials showed statistically significant reductions in fasting glucose, the clinical significance of these reductions was uncertain and results were not consistent across studies. Importantly, most trials used Cassia cinnamon rather than Ceylon cinnamon specifically, making it difficult to draw firm conclusions about Ceylon cinnamon in isolation.^[5][6] Researchers have called for larger, well-designed trials before any recommendations can be made.

There is currently no official link established between Ceylon cinnamon supplementation and clinically meaningful improvements in HbA1c or long-term diabetes outcomes. NICE guidelines on type 2 diabetes management focus on lifestyle modification, structured education programmes, and evidence-based pharmacological treatments; cinnamon is not mentioned as a recommended intervention.^[11] People with diabetes should not interpret the existing evidence as a reason to alter their prescribed treatment regimen.

Is it safe to take Ceylon cinnamon alongside diabetes medication?

Ceylon cinnamon may have an additive blood sugar lowering effect with insulin or sulfonylureas, raising hypoglycaemia risk; always consult your GP or diabetes team before starting supplementation.

Taking Ceylon cinnamon alongside prescribed diabetes medication carries a potential risk of additive blood sugar lowering, which could increase the likelihood of hypoglycaemia (low blood sugar) in some individuals. This is particularly relevant for people taking insulin, sulfonylureas (such as gliclazide or glibenclamide), or other glucose-lowering medicines where hypoglycaemia is already a recognised adverse effect. The NHS provides patient-facing guidance on recognising and managing hypoglycaemia, and people with diabetes should familiarise themselves with this as part of their care plan.

Ceylon cinnamon contains significantly lower levels of coumarin than Cassia cinnamon, which reduces the risk of liver toxicity associated with high or prolonged coumarin intake.^[2][3] The European Food Safety Authority (EFSA) has established a tolerable daily intake for coumarin of 0.1 mg per kilogram of body weight, and Ceylon cinnamon is generally considered safer for regular use on this basis. Nevertheless, 'safer' does not mean risk-free, and high doses of any supplement can have unintended effects.

People with pre-existing liver disease should avoid high-dose cinnamon supplements without medical advice. If you develop symptoms that could suggest liver problems, such as yellowing of the skin or eyes (jaundice), dark urine, or persistent abdominal pain, stop taking the supplement and seek prompt medical advice.

Anyone taking medication for type 2 diabetes, or any other condition, should speak to their GP or diabetes care team before starting a cinnamon supplement. This is especially important for people whose blood sugar is already well controlled, as even a small additional lowering effect could push glucose levels too low. Symptoms of hypoglycaemia include shakiness, sweating, confusion and palpitations, and should be treated promptly. If you experience these symptoms, follow your diabetes management plan and contact your GP if they occur frequently or unexpectedly.

Pregnant or breastfeeding women, and parents considering supplements for children, should not use high-dose cinnamon supplements without first consulting a healthcare professional.

Suspected adverse effects from supplements can be reported to the MHRA via the Yellow Card scheme at yellowcard.^[13][14]mhra.gov.uk.

What do NHS and UK health guidelines say about cinnamon supplements?

Neither NICE nor the NHS recommends cinnamon supplements for diabetes management; they are regulated as food supplements, not medicines, and cannot legally claim to treat any condition.

Neither the NHS nor NICE currently recommends cinnamon supplements as part of the management of type 2 diabetes, prediabetes or any other blood sugar condition. NICE guidelines on type 2 diabetes management (NG28 and its updates) focus on lifestyle modification, structured education programmes, and evidence-based pharmacological treatments. Cinnamon is not mentioned as a recommended intervention in any current NICE guideline or NHS clinical pathway.

The NHS advises that people with diabetes should follow a balanced diet, engage in regular physical activity, and take any prescribed medication as directed by their healthcare team. While the NHS acknowledges that some people use complementary approaches, it consistently emphasises that these should not replace conventional treatment and that patients should always inform their GP or diabetes nurse of any supplements they are taking.

Dietary supplements, including cinnamon capsules, are regulated as food supplements in the UK rather than as medicines. This means they are not subject to the same rigorous pre-market efficacy and safety testing required for licensed medicines. Manufacturers of food supplements are not permitted to make medicinal claims, such as stating that a product treats or prevents diabetes.^[12] When choosing a cinnamon supplement, look for products that clearly state the species as Cinnamomum verum on the label, are supplied by a reputable UK-based food business operator, and do not make claims about treating or preventing any medical condition.

For people seeking support with weight management or blood sugar concerns through an online service, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support, where clinically appropriate treatments may be considered. People with diabetes should always keep their GP informed of any additional interventions they are exploring.

How much Ceylon cinnamon would you need to take to see any effect?

No effective dose has been established or approved; trials used 1 g to 6 g daily, far exceeding culinary amounts, and no dose-response relationship has been confirmed for Ceylon cinnamon specifically.

There is no established effective dose of Ceylon cinnamon for blood sugar management, and no dose has been approved or recommended by any UK regulatory or clinical body. The doses used in published clinical trials have varied considerably, typically ranging from 1 g to 6 g per day of cinnamon powder or equivalent extract, taken for periods of between four and sixteen weeks, based on the range reported across available systematic reviews and randomised controlled trials.^[5][6] This wide variation makes it difficult to identify a consistent dose-response relationship.

It is worth noting that the majority of trials used Cassia cinnamon rather than Ceylon cinnamon. Because Ceylon cinnamon may contain lower concentrations of some of the active compounds thought to influence blood sugar, including cinnamaldehyde, it is possible that different quantities might be needed to achieve a comparable effect, though this has not been formally studied and remains hypothetical.

From a practical standpoint, the amounts used in trials are substantially higher than the quantities typically consumed through cooking or food. A teaspoon of ground cinnamon is approximately 2 g to 3 g (this is an approximation and will vary by grind and packing), so achieving trial-level doses through diet alone would require consuming several teaspoons daily, which is neither palatable nor advisable without medical supervision. Culinary use is unlikely to replicate the doses studied in trials.

If you are not certain that a product contains Ceylon cinnamon (Cinnamomum verum) rather than Cassia, be aware that Cassia carries a higher coumarin content, and the EFSA tolerable daily intake for coumarin is 0.1 mg per kilogram of body weight per day. High or prolonged intake of Cassia-based products could approach or exceed this limit at supplement doses.

Given the absence of a proven effective dose, the lack of regulatory guidance, and the potential for interactions with diabetes medication, it would not be appropriate to self-prescribe a specific quantity of Ceylon cinnamon for blood sugar management. Anyone considering supplementation should discuss this with their GP or a registered dietitian, who can provide personalised advice based on their full medical history and current treatment plan.

Scientific References

1. Cinnamomum cortex - Addendum Assessment Report (Cinnamomum verum).
2. Application of HPLC-UV combined with chemometrics for the detection and quantification of 'true cinnamon' adulteration.
3. Evaluation of on-site testing methods with a novel 3-in-1 miniaturized spectroscopic device for cinnamon screening.
4. Discrimination of four cinnamon species.
5. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis.
6. The effects of cinnamon on patients with metabolic diseases: an umbrella review of meta-analyses of randomized controlled trials.
7. Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis.
8. The impact of cinnamon on anthropometric indices and glycemic status in patients with type 2 diabetes: a systematic review and meta-analysis of clinical trials.
9. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial.
10. The efficacy and safety of berberine in combination with cinnamon supplementation in patients with type 2 diabetes: a randomized clinical trial.
11. Type 2 diabetes in adults: management. Guideline NG28.
12. Nutrition legislation information sheet.
13. Adverse reactions to drugs — Yellow Card scheme.
14. Every report to MHRA's Yellow Card scheme helps improve the safety of medicines and medical devices for all.
15. Efficacy and Safety of Cinnamomum zeylanicum (Ceylon cinnamon) for diabetes mellitus: a randomized, double blind, placebo-controlled clinical trial.
16. Effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract on lipid profile, glucose levels and its safety in adults: a randomized, double-blind, controlled trial.

Frequently Asked Questions